StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO
In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week by pricing the largest-ever IPO by a drug develop…
Read guide →